Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 842

1.

Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.

Firooz A, Ghandi N, Hallaji Z, Chams-Davatchi C, Valikhani M, Karbakhsh Davari M.

Arch Dermatol. 2008 Sep;144(9):1143-7. doi: 10.1001/archderm.144.9.1143.

PMID:
18794458
[PubMed - indexed for MEDLINE]
2.

Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.

Olszewska M, Kolacinska-Strasz Z, Sulej J, Labecka H, Cwikla J, Natorska U, Blaszczyk M.

Am J Clin Dermatol. 2007;8(2):85-92.

PMID:
17428113
[PubMed - indexed for MEDLINE]
3.

Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.

Gisbert JP, Niño P, Rodrigo L, Cara C, Guijarro LG.

Am J Gastroenterol. 2006 Dec;101(12):2769-76. Epub 2006 Oct 6.

PMID:
17026564
[PubMed - indexed for MEDLINE]
4.

Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.

Ansari A, Hassan C, Duley J, Marinaki A, Shobowale-Bakre EM, Seed P, Meenan J, Yim A, Sanderson J.

Aliment Pharmacol Ther. 2002 Oct;16(10):1743-50.

PMID:
12269967
[PubMed - indexed for MEDLINE]
Free Article
5.

Thiopurine methyltransferase activity in Spain: a study of 14,545 patients.

Gisbert JP, Gomollón F, Cara C, Luna M, González-Lama Y, Pajares JM, Maté J, Guijarro LG.

Dig Dis Sci. 2007 May;52(5):1262-9. Epub 2007 Mar 2.

PMID:
17334911
[PubMed - indexed for MEDLINE]
6.

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

Meggitt SJ, Gray JC, Reynolds NJ.

Lancet. 2006 Mar 11;367(9513):839-46.

PMID:
16530578
[PubMed - indexed for MEDLINE]
7.
8.
9.

The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients.

Chocair PR, Duley JA, Simmonds HA, Cameron JS.

Transplantation. 1992 May;53(5):1051-6.

PMID:
1585469
[PubMed - indexed for MEDLINE]
10.

Thiopurine methyltransferase (TPMT) heterozygosity and enzyme activity as predictive tests for the development of azathioprine-related adverse events.

Heckmann JM, Lambson EM, Little F, Owen EP.

J Neurol Sci. 2005 Apr 15;231(1-2):71-80.

PMID:
15792824
[PubMed - indexed for MEDLINE]
11.

Human thiopurine S-methyltransferase activity in uremia and after renal transplantation.

Weyer N, Kröplin T, Fricke L, Iven H.

Eur J Clin Pharmacol. 2001 May;57(2):129-36.

PMID:
11417444
[PubMed - indexed for MEDLINE]
12.

Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.

Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA.

Pharmacogenetics. 2002 Aug;12(6):429-36.

PMID:
12172211
[PubMed - indexed for MEDLINE]
13.

Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.

Xin HW, Xiong H, Wu XC, Li Q, Xiong L, Yu AR.

Eur J Clin Pharmacol. 2009 Mar;65(3):249-55. doi: 10.1007/s00228-008-0589-0. Epub 2008 Dec 2.

PMID:
19048245
[PubMed - indexed for MEDLINE]
14.

[Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients].

Gisbert JP, Gomollón F, Cara C, Luna M, González-Lama Y, Pajares JM, Maté J, Guijarro LG.

Med Clin (Barc). 2005 Sep 10;125(8):281-5. Spanish.

PMID:
16159550
[PubMed - indexed for MEDLINE]
15.

Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.

Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM.

Hepatogastroenterology. 2006 May-Jun;53(69):399-404.

PMID:
16795981
[PubMed - indexed for MEDLINE]
16.

Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine.

Campbell S, Kingstone K, Ghosh S.

Aliment Pharmacol Ther. 2002 Mar;16(3):389-98.

PMID:
11876691
[PubMed - indexed for MEDLINE]
Free Article
17.

The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.

Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, Domański L, Droździk M.

Ther Drug Monit. 2005 Aug;27(4):435-41.

PMID:
16044099
[PubMed - indexed for MEDLINE]
18.

Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.

Pettersson B, Almer S, Albertioni F, Söderhäll S, Peterson C.

Ther Drug Monit. 2002 Jun;24(3):351-8.

PMID:
12021625
[PubMed - indexed for MEDLINE]
19.

Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.

Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C.

J Am Soc Nephrol. 2001 Jan;12(1):170-6.

PMID:
11134264
[PubMed - indexed for MEDLINE]
Free Article
20.

[Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine].

Gisbert JP, Luna M, Maté J, González-Guijarro L, Cara C, Pajares JM.

Med Clin (Barc). 2003 Jun 7;121(1):1-5. Spanish.

PMID:
12812701
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk